Clinical trial · Observational
Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
Study of Cases and Controls on Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
NCT01525199CI-TRIAL-00014249IDENTIFYcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this trial is to compare the evolution of patients receiving first line treatment for locally advanced or metastatic lung cancer, taking into account if they were requested or not the EGFR mutation test as part of the diagnosis and treatment strategy. There is no assignment to any particular therapeutic strategy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
| Stage IIIB/IV | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Case
- label
- Control
Primary outcomes (3)
- measure
- Disease free survival
- timeFrame
- 12 months after the diagnosis of advanced disease
- measure
- Overall Survival
- timeFrame
- 12 months after the diagnosis of advanced disease
- measure
- Number of hospitalizations
- timeFrame
- 12 months after the diagnosis of advanced disease
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with confirmed diagnosis of lung adenocarcinoma, stage IIIb/IV. * Patients under 1st line treatment against lung adenocarcinoma. Exclusion Criteria: * Patients not having the information required by the protocol.
References
Publications (0)
Data not yet available
No reference posted for this study.